메뉴 건너뛰기




Volumn 51, Issue 9, 2007, Pages 1277-1279

The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome

Author keywords

Coagulopathy; Ehlers Danlos syndrome vascular type; Haemostasis; Recombinant factor VIIa

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

EID: 34548590845     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01416.x     Document Type: Article
Times cited : (17)

References (21)
  • 1
    • 0036314742 scopus 로고    scopus 로고
    • Clinical and genetic features of vascular Ehlers-Danlos syndrome
    • Germain DP. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg 2002 16 : 391 7.
    • (2002) Ann Vasc Surg , vol.16 , pp. 391-7
    • Germain, D.P.1
  • 2
    • 0029780318 scopus 로고    scopus 로고
    • The surgical complications of Ehlers-Danlos syndrome
    • Freeman RK, Swegle J. The surgical complications of Ehlers-Danlos syndrome. Am Surg 1996 62 : 869 73.
    • (1996) Am Surg , vol.62 , pp. 869-73
    • Freeman, R.K.1    Swegle, J.2
  • 3
    • 22044433881 scopus 로고    scopus 로고
    • The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV. a 30-year experience
    • Oderich GS, Panneton JM, Bower TC et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV. A 30-year experience. J Vasc Surg 2005 42 : 98 106.
    • (2005) J Vasc Surg , vol.42 , pp. 98-106
    • Oderich, G.S.1    Panneton, J.M.2    Bower, T.C.3
  • 4
    • 0034054910 scopus 로고    scopus 로고
    • Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
    • Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000 342 : 673 80.
    • (2000) N Engl J Med , vol.342 , pp. 673-80
    • Pepin, M.1    Schwarze, U.2    Superti-Furga, A.3    Byers, P.H.4
  • 5
    • 0030908067 scopus 로고    scopus 로고
    • DDAVP therapy controls bleeding in Ehlers-Danlos syndrome
    • Stine KC, Becton DL. DDAVP therapy controls bleeding in Ehlers-Danlos syndrome. J Paediatr Hematol Oncol 1997 19 : 156 8.
    • (1997) J Paediatr Hematol Oncol , vol.19 , pp. 156-8
    • Stine, K.C.1    Becton, D.L.2
  • 6
    • 0030010244 scopus 로고    scopus 로고
    • The Ehlers-Danlos syndrome: A heritable collagen disorder as cause of bleeding
    • de Paepe A. The Ehlers-Danlos syndrome: a heritable collagen disorder as cause of bleeding. Thromb Haemost 1996 75 : 379 86.
    • (1996) Thromb Haemost , vol.75 , pp. 379-86
    • De Paepe, A.1
  • 7
    • 33646484250 scopus 로고    scopus 로고
    • Spontaneous mesenteric hemorrhage associated with Ehlers-Danlos syndrome
    • Hosaka A, Miyata T, Shigematsu H et al. Spontaneous mesenteric hemorrhage associated with Ehlers-Danlos syndrome. J Gastrointest Surg 2006 10 : 583 5.
    • (2006) J Gastrointest Surg , vol.10 , pp. 583-5
    • Hosaka, A.1    Miyata, T.2    Shigematsu, H.3
  • 8
    • 0018906549 scopus 로고
    • Anesthetic considerations for Ehlers-Danlos syndrome
    • Dolan P, Sisko F. Anesthetic considerations for Ehlers-Danlos syndrome. Anesthesiology 1980 52 : 266 9.
    • (1980) Anesthesiology , vol.52 , pp. 266-9
    • Dolan, P.1    Sisko, F.2
  • 9
    • 33746999573 scopus 로고    scopus 로고
    • Anaesthetic implications of vascular type Ehlers-Danlos syndrome
    • Lane D. Anaesthetic implications of vascular type Ehlers-Danlos syndrome. Anaesth Intensive Care 2006 34 : 501 5.
    • (2006) Anaesth Intensive Care , vol.34 , pp. 501-5
    • Lane, D.1
  • 10
    • 0030467134 scopus 로고    scopus 로고
    • Respiratory complications of Ehlers-Danlos syndrome type IV
    • Dowton SB, Pincott S, Demmer L. Respiratory complications of Ehlers-Danlos syndrome type IV. Clin Genet 1996 50 : 510 4.
    • (1996) Clin Genet , vol.50 , pp. 510-4
    • Dowton, S.B.1    Pincott, S.2    Demmer, L.3
  • 11
    • 0024370333 scopus 로고
    • Two cases of myocardial infarction in type IV Ehlers-Danlos syndrome
    • Kitazono T, Imazumi T, Imayama S et al. Two cases of myocardial infarction in type IV Ehlers-Danlos syndrome. Chest 1989 95 : 1274 7.
    • (1989) Chest , vol.95 , pp. 1274-7
    • Kitazono, T.1    Imazumi, T.2    Imayama, S.3
  • 12
    • 0030065955 scopus 로고    scopus 로고
    • Myocardial ischaemia associated with Ehlers-Danlos syndrome
    • Price CM, Ford S, St John Jones L, Murday V. Myocardial ischaemia associated with Ehlers-Danlos syndrome. Br J Anaesth 1996 76 : 464 6.
    • (1996) Br J Anaesth , vol.76 , pp. 464-6
    • Price, C.M.1    Ford, S.2    St John Jones, L.3    Murday, V.4
  • 13
    • 0036110510 scopus 로고    scopus 로고
    • Fluid resuscitation of the patient with major trauma
    • Fowler R, Pepe PE. Fluid resuscitation of the patient with major trauma. Curr Opin Anaesthesiol 2002 15 : 173 8.
    • (2002) Curr Opin Anaesthesiol , vol.15 , pp. 173-8
    • Fowler, R.1    Pepe, P.E.2
  • 14
    • 0035067623 scopus 로고    scopus 로고
    • Ehlers-Danlos syndrome mimicking mesenteric vasculitis: Therapy, then diagnosis
    • Bloch R, Hoffer E, Borsa J, Fontaine A. Ehlers-Danlos syndrome mimicking mesenteric vasculitis: therapy, then diagnosis. J Vasc Intervent Radiol 2001 12 : 527 9.
    • (2001) J Vasc Intervent Radiol , vol.12 , pp. 527-9
    • Bloch, R.1    Hoffer, E.2    Borsa, J.3    Fontaine, A.4
  • 15
    • 33748868658 scopus 로고    scopus 로고
    • Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery
    • Karkouti K, Yau TM, Riazi S et al. Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery. Can J Anaesth 2006 53 : 802 9.
    • (2006) Can J Anaesth , vol.53 , pp. 802-9
    • Karkouti, K.1    Yau, T.M.2    Riazi, S.3
  • 16
    • 33846443612 scopus 로고    scopus 로고
    • Recombinant activated factor VII in cardiac surgery: A systematic review
    • Warren O, Mandal K, Hadjianastassiou V et al. Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 2007 83 : 707 14.
    • (2007) Ann Thorac Surg , vol.83 , pp. 707-14
    • Warren, O.1    Mandal, K.2    Hadjianastassiou, V.3
  • 17
    • 30944461398 scopus 로고    scopus 로고
    • Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
    • O'Connell KA, Wood JJ, Wise RP et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. J Am Med Assoc 2006 295 : 293 8.
    • (2006) J Am Med Assoc , vol.295 , pp. 293-8
    • O'Connell, K.A.1    Wood, J.J.2    Wise, R.P.3
  • 18
    • 33749019450 scopus 로고    scopus 로고
    • Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa
    • Sugg RM, Gonzales NR, Matherne DE et al. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 2006 67 : 1053 5.
    • (2006) Neurology , vol.67 , pp. 1053-5
    • Sugg, R.M.1    Gonzales, N.R.2    Matherne, D.E.3
  • 19
    • 33846034540 scopus 로고    scopus 로고
    • Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukaemia and intractable bleeding
    • Mantzios G, Tsirigotis P, Pappa V et al. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukaemia and intractable bleeding. Eur J Haematol 2007 78 : 173 4.
    • (2007) Eur J Haematol , vol.78 , pp. 173-4
    • Mantzios, G.1    Tsirigotis, P.2    Pappa, V.3
  • 20
    • 33846925118 scopus 로고    scopus 로고
    • Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
    • Ng HJ, Lee LH. Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients. Vasc Health Risk Manag 2006 2 : 433 40.
    • (2006) Vasc Health Risk Manag , vol.2 , pp. 433-40
    • Ng, H.J.1    Lee, L.H.2
  • 21
    • 33749116919 scopus 로고    scopus 로고
    • Recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type a aortic dissection
    • Faber P, Reid C, El-Shafei H et al. Recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type A aortic dissection. J Cardiothorac Vasc Anesth 2006 20 : 736 41.
    • (2006) J Cardiothorac Vasc Anesth , vol.20 , pp. 736-41
    • Faber, P.1    Reid, C.2    El-Shafei, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.